Limitations of the PRODIGE 7 trial
Lancet Oncol
.
2021 May;22(5):e177.
doi: 10.1016/S1470-2045(21)00096-6.
Author
Peter Cashin
1
Affiliation
1
Department of Surgical Sciences, Uppsala University Hospital, Uppsala 75185, Sweden. Electronic address: peter.cashin@surgsci.uu.se.
PMID:
33932375
DOI:
10.1016/S1470-2045(21)00096-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Colorectal Neoplasms* / drug therapy
Cytoreduction Surgical Procedures
Humans
Hyperthermic Intraperitoneal Chemotherapy
Leucovorin / therapeutic use
Peritoneal Neoplasms*
Substances
Leucovorin